These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26593438)

  • 1. A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy.
    Turan B
    Curr Drug Deliv; 2016; 13(3):418-23. PubMed ID: 26593438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart.
    Tuncay E; Okatan EN; Vassort G; Turan B
    PLoS One; 2013; 8(7):e71014. PubMed ID: 23923043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cardiac β3-adrenergic receptors in hyperglycemia.
    Turan B; Tuncay E
    Indian J Biochem Biophys; 2014 Dec; 51(6):483-92. PubMed ID: 25823220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats.
    Bilginoglu A; Seymen A; Tuncay E; Zeydanli E; Aydemir-Koksoy A; Turan B
    Cardiovasc Toxicol; 2009 Mar; 9(1):21-9. PubMed ID: 19294534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.
    Cicek FA; Toy A; Tuncay E; Can B; Turan B
    J Bioenerg Biomembr; 2014 Oct; 46(5):377-87. PubMed ID: 25064604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound cardioprotection with timolol in a female rat model of aging-related altered left ventricular function.
    Sozmen NN; Tuncay E; Bilginoglu A; Turan B
    Can J Physiol Pharmacol; 2011 Apr; 89(4):277-88. PubMed ID: 21526975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with a beta-blocker timolol attenuates renal-damage in diabetic rats via enhancing kidney antioxidant-defense system.
    Gokturk H; Ulusu NN; Gok M; Tuncay E; Can B; Turan B
    Mol Cell Biochem; 2014 Oct; 395(1-2):177-86. PubMed ID: 24947049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy and oxidative stress: role of antioxidants.
    Thandavarayan RA; Giridharan VV; Watanabe K; Konishi T
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):225-30. PubMed ID: 21902660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system.
    Okatan EN; Tuncay E; Turan B
    J Nutr Biochem; 2013 Dec; 24(12):2110-8. PubMed ID: 24183307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy.
    Carillion A; Feldman S; Na N; Biais M; Carpentier W; Birenbaum A; Cagnard N; Loyer X; Bonnefont-Rousselot D; Hatem S; Riou B; Amour J
    PLoS One; 2017; 12(7):e0180103. PubMed ID: 28727746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of cardiac β-adrenoceptor subtypes in the cardiac left ventricle of rats with metabolic syndrome: Comparison with streptozotocin-induced diabetic rats.
    Okatan EN; Tuncay E; Hafez G; Turan B
    Can J Physiol Pharmacol; 2015 Jul; 93(7):517-25. PubMed ID: 25994289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart?
    Maslov LN; Naryzhnaya NV; Voronkov NS; Kurbatov BK; Derkachev IA; Ryabov VV; Vyshlov EV; Kolpakov VV; Tomilova EA; Sapozhenkova EV; Singh N; Fu F; Pei J
    Fundam Clin Pharmacol; 2024 Aug; 38(4):658-673. PubMed ID: 38423796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation.
    Rani N; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
    Chem Biol Interact; 2016 Apr; 250():59-67. PubMed ID: 26972669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats.
    He H; Liu Q; Shi M; Zeng X; Yang J; Wu L; Li L
    Phytother Res; 2008 Aug; 22(8):1107-14. PubMed ID: 18570267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
    Salie R; Moolman JA; Lochner A
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts.
    Dinçer UD; Bidasee KR; Güner S; Tay A; Ozçelikay AT; Altan VM
    Diabetes; 2001 Feb; 50(2):455-61. PubMed ID: 11272160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains.
    Rybin VO; Pak E; Alcott S; Steinberg SF
    Mol Pharmacol; 2003 Jun; 63(6):1338-48. PubMed ID: 12761344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.
    Saklani R; Gupta SK; Mohanty IR; Kumar B; Srivastava S; Mathur R
    Mol Cell Biochem; 2016 Sep; 420(1-2):65-72. PubMed ID: 27443845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
    Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
    Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.